V009-4970 Screening compound: N-{1-[4-({3-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide

V009-4970 Screening compound: N-{1-[4-({3-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide
V009-4970 Screening compound: N-{1-[4-({3-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-4970
N-{1-[4-({3-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-4970

Molecular Formula

C27H32ClN5O3 (C27 H32 ClN5 O3)

Compound Name

N-{1-[4-({3-[5-(3-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide

IUPAC name

N-{1-[4-({3-[5-(3-chlorophenyl)-124-oxadiazol-3-yl]phenyl}methyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl}acetamide

SMILES

CC(C)CC(C(N1CCN(Cc2cccc(-c3noc(-c4cccc(Cl)c4)n3)c2)CC1)=O)NC(C)=O

InChI

InChI=1S/C27H32ClN5O3/c1-18(2)14-24(29-19(3)34)27(35)33-12-10-32(11-13-33)17-20-6-4-7-21(15-20)25-30-26(36-31-25)22-8-5-9-23(28)16-22/h4-9,15-16,18,24H,10-14,17H2,1-3H3,(H,29,34)/t24-/m0/s1

InChI Key

SWHCEFCHZQMDKZ-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD19962241

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

510.04

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.209

Distribution Coefficient, logD

4.208

Water Solubility, LogSw

-4.47

Polar Surface Area

76.319

Acid Dissociation Constant (pKa)

12.60

Base Dissociation Constant (pKb)

4.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

V009-4970 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with V009-4970 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-4970?
Check Price and Availability of V009-4970, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-4970 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-4970
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-4970
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-4970 available by request